What is a general principle for breakthrough pain management in patients on chronic opioid therapy?

• A. Use a long-acting opioid for breakthrough pain.
• B. Provide a rapid-onset opioid for breakthrough episodes; typical dose is a small percentage (often 5–15%) of total daily opioid dose per episode; tailor to pain intensity and duration; use fast-acting formulations.
• C. Increase the baseline opioid dose for all pain episodes.
• D. Avoid any breakthrough analgesia altogether.

Answer: (B)

A general principle for managing breakthrough pain in patients on chronic opioid therapy is to use a rapid-onset, short-acting rescue opioid for each breakthrough episode while continuing the existing baseline opioid regimen. This approach provides quick relief exactly when the episodic pain occurs, without waiting for a slower, long-acting formulation to take effect.

The rescue dose should be a small fraction of the total daily opioid dose and is adjusted based on how severe the breakthrough pain is and how long it lasts, using fast-acting formulations designed for rapid onset. This allows precise titration to the patient’s needs and minimizes the risk of overdose or sedation from a mismatched dose.

Long-acting opioids aren’t appropriate for breakthrough episodes because they don’t act quickly enough to relieve sudden pain. Increasing the baseline opioid dose for all pain episodes isn’t ideal either, as it raises the risk of tolerance, dependence, and adverse effects. Having no breakthrough analgesia leaves episodic pain untreated and can impair function and quality of life.